UNSPSC 51284019: Chlortetracycline calcium

This classification denotes a tetracycline antibiotic C22H23ClN2O8.Ca, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier NR4B2SX17S, chemically known as 7-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide calcium salt, but more generally known as chlortetracycline calcium, which bears US NIH Compound Identifier 71458158. Most nations, for tariff and trade purposes, schedule chlortetracycline calcium under HS 29413000 and SITC 54133.

As of Q4 2014, CHLORTETRACYCLINE CALCIUM remains US FDA's Preferred Term for this commodity. Chlortetracycline calcium bears US NLM identifiers UMLS ID C2723846 and NCI Concept Code C80800. SMILES: C[C@]1(C2C(CCC(C2C(=O)C3=C([C@]4([C@@H](C[C@@H]31)[C@@H](C(=C(C4=O)C(=O)N)O)N(C)C)O)O)O)CL)O.[CA+2].

UNSPSC 51284019 Chlortetracycline calcium is a Commodity code that encompasses pharmaceutical products used in state and local health and emergency response initiatives. Recent state and local opportunities tagged under this code reflect purchases of antibiotics and emergency medical supplies rather than the narrow scope the code name suggests — the Illinois Department of Public Health procured Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets through a piggyback pharmaceutical warehouse contract awarded to Chartwell Rx LLC in August 2026, while Seminole County, Florida sought 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually through competitive bidding. Issuing bodies under this code include state health departments and county community health programs; both manage pharmaceutical supply chains for disease management, emergency preparedness, and opioid-response initiatives rather than purchasing chlortetracycline specifically.

The most recent activity appears concentrated in the South and Midwest, with posted opportunities from Florida and Illinois in mid-2026. The Illinois Department of Public Health awarded a $2,999,999.11 contract over 12 months plus two optional renewal years through the MMCAP Infuse consortium piggyback vehicle to supply Doxycycline Hyclate and Ciprofloxacin Hydrochloride in 20-count tablet packages; Chartwell Rx LLC was selected as the lowest responsive bidder under an IFB process with no set-aside requirements. Seminole County's IFB 60459723LAS, posted June 30, 2026, with response deadline July 26, 2026, required quarterly deliveries of Naloxone and drug deactivation systems with electronic bidding through the county's e-Procurement Portal and compliance with E-Verify and drug-free workplace certification. The code shows limited recent activity overall, and tagged opportunities diverge materially from chlortetracycline calcium procurement.